Karyopharm Therapeutics Inc. - Common Stock (KPTI)

8.1600
+0.9100 (12.55%)
NASDAQ · Last Trade: Apr 9th, 11:23 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026